Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0306
-0.0004 (-1.29%)
At close: Aug 15, 2025
Petros Pharmaceuticals Employees
Petros Pharmaceuticals had 18 employees as of December 31, 2024. The number of employees decreased by 3 or -14.29% compared to the previous year.
Employees
18
Change (1Y)
-3
Growth (1Y)
-14.29%
Revenue / Employee
$205,032
Profits / Employee
$1,925,317
Market Cap
1.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Petros Pharmaceuticals News
- 7 weeks ago - Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position - Accesswire
- 3 months ago - Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets - Accesswire
- 3 months ago - Petros Pharmaceuticals partners with Innolitics to accelerate SaaS platform development - Seeking Alpha
- 3 months ago - Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer - Accesswire
- 3 months ago - Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - Accesswire
- 3 months ago - Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches - Accesswire
- 3 months ago - Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms - Accesswire
- 5 months ago - Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - Accesswire